SARPREET BASRA, M.D.
Gastroenterology Physician in LAKE CHARLES, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SARPREET BASRA, M.D. reported a CMS MIPS final score of 75.2395/100 — below the 83.1 national average — and filed 1,953 Medicare Part D claims in 2023.
- 75.2395/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SARPREET BASRA, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
SARPREET BASRA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SARPREET BASRA, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Louisiana
How Gastroenterology Physician compares to other specialties among Louisiana providers
Gastroenterology Physician share within Louisiana
Gastroenterology Physician is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
SARPREET BASRA, M.D.'s 2023 MIPS final score plotted against the Gastroenterology Physician national average
- MIPS Final Score
- 75.2395/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Gastroenterology Physician) — 75.2395/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Gastroenterology Physician US NPIs
75.2395/100 MIPS final score — 7.9 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Gastroenterology Physician. Quality dim: 89.4073. Cost dim: 23.6585.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SARPREET BASRA, M.D. appears in the CMS NPPES registry as a Gastroenterology Physician provider holding M.D. credentials at 2770 3RD AVE STE 345, LAKE CHARLES, LA, 70601, with a listed phone of (337) 494-4785. NPI 1427224765 was issued on 05/06/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BASRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,953 prescription claims written by this provider, covering 739 Medicare beneficiaries and totaling roughly $621K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.2395/100 for the 2023 performance year (Quality 89.4073, Cost 23.6585), compared with the national average of 83.1.
Gastroenterology Physician is a mid-sized specialty nationwide, with 16,567 enrolled providers across 54 states and an average of 833 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1427224765 |
|---|---|
| Specialty | Gastroenterology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/06/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SARPREET BASRA, M.D.'s current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where SARPREET BASRA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARPREET BASRA, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.7K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,777
- Total Day Supply
- 67,391
- Generic Drug Cost
- $42K
- Antibiotic Claims
- 62
Patient Demographics
- Average Patient Age
- 68.3 years
- Avg HCC Risk Score
- 1.34
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 171, 65-74: 392, 75-84: 151, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SARPREET BASRA, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
658 claims
- Linzess 126
Linzess
126 claims
- Dicyclomine Hcl 92
Dicyclomine Hcl
92 claims
- Sucralfate 79
Sucralfate
79 claims
- Omeprazole 70
Omeprazole
70 claims
- Clenpiq 60
Clenpiq
60 claims
- Metoclopramide Hcl 60
Metoclopramide Hcl
60 claims
- Famotidine 45
Famotidine
45 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 658 |
| Linzess Linaclotide | 126 |
| Dicyclomine Hcl | 92 |
| Sucralfate | 79 |
| Omeprazole | 70 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 60 |
| Metoclopramide Hcl | 60 |
| Famotidine | 45 |
| Ondansetron Hcl | 37 |
| Colestipol Hcl | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gastroenterology Physician Overview
How SARPREET BASRA, M.D. fits within the Gastroenterology Physician landscape nationally.
SARPREET BASRA, M.D.'s 1,953 claims are above the specialty average of 833.
Nearby Gastroenterology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as BASRA.
Compare Gastroenterology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is SARPREET BASRA, M.D.'s specialty? ▼
How much does SARPREET BASRA, M.D. prescribe under Medicare Part D? ▼
What is SARPREET BASRA, M.D.'s Medicare quality score? ▼
Where is SARPREET BASRA, M.D. located? ▼
What is SARPREET BASRA, M.D.'s NPI number? ▼
How many Gastroenterology Physician providers are there in the US? ▼
What drugs does SARPREET BASRA, M.D. prescribe most often? ▼
Does SARPREET BASRA, M.D. accept Medicare? ▼
How can I verify SARPREET BASRA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology